Here we review the role of tissutal and circulating biomarkers in the management of lung cancer. In the past they were considerate quite ineffective tools as regards prognosis and prediction of treatment activity, nowadays instead, they are becoming a crucial key point as potential predictive issues in driving therapy, with possibly prognostic values as well.
|Number of pages||6|
|Journal||Frontiers in Bioscience - Elite|
|Publication status||Published - 2010|
ASJC Scopus subject areas